You’re Invited to Make Waves in Cancer Research |
Save the date for the 2025 Legends of Science and Surfing, where groundbreaking science meets the soul of surfing. This year’s two-day event is unlike any other, uniting global leaders in science and surfing for an unforgettable weekend of innovation, collaboration and community. Proceeds from this extraordinary gathering will directly support Moores Cancer Center at UC San Diego Health, San Diego’s only National Cancer Institute-designated comprehensive cancer center, which advances life-saving research and care.
|
|
|
Registration Now Open: Free Compassionate Communication Workshop Series
|
This free, skills-based program is specially designed for health care professionals, medical educators, and researchers. Through interactive sessions, participants will learn how to communicate with greater compassion—and, in turn, greater effectiveness—with patients, health care teams, medical trainees, and beyond.
|
|
|
FEATURED FUNDING OPPORTUNITIES
|
Stand Up to Cancer (SU2C) Lung Cancer Early Detection Challenge
|
SU2C evaluates platforms for liquid biopsies for the early detection of lung cancer prior to treatment in smokers to improve patient outcomes. For more information and to apply, go to Proposal Central, search Stand Up To Cancer under Grant Opportunities, and begin the application process.
Grant Amount: $150-$200K for 12-18 months
Application Deadline: October 2, 2025
|
This award supports collaborative research for investigators with diverse expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. Teams of three or more investigators are granted awards to generate and integrate data from diverse lines of research to advance treatment for cancer patients that could not be achieved through individual research.
Grant Amount: $3M for 3 years
Application Deadline: July 21, 2025
|
|
|
| BRAF V600E-positive mononuclear cells in blood at diagnosis portend treatment failure and neurodegeneration in pediatric LCH |
Deborah E. Schiff, MD (Hematologic Malignancies)
|
|
|
|
| A Novel Adjuvant Chemoradiotherapy/Immunotherapy for Resected Biliary Cancer |
Andrew M. Lowy, MD, FACS (Solid Tumor Therapeutics)
|
|
|
| Cytoscape Web: bringing network biology to the browser
|
Trey Ideker, PhD (Structural and Functional Genomics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
No newly opened clinical trials.
|
|
|
The Researcher Spotlight is designed to help you connect with fellow researchers, gain insights into their diverse projects, and discover the paths that led them to their current roles. Uncover a personal touch to their professional achievements, showcasing the varied perspectives within our cancer research community.
|
Dr. Kaufman is a board-certified hematologist who specializes in caring for patients with blood cancers such as leukemia, lymphoma and myeloma. He uses human pluripotent stem cells to understand blood cells and related mesodermal cell populations. Dr. Kaufman and his team develop new clinical applications for treating relapsed or refractory cancers, including both hematologic malignancies and solid tumors.
|
|
|
|
